FAS and ischemic stroke: Moreover, TRAF1-mediated neuronal death was completely abrogated when Fas–Fc and anti-FasL antibodies were employed (Supplementary Fig. S12), suggesting that the Fas/FasL pathway is a major TRAF1 target during ischaemic stroke.